Article
Exploring sex differences in endocannabinoid system biomarkers and their relationship with antidepressant treatment outcomes in major depressive disorder: a CAN-BIND 1 secondary analysis.
European archives of psychiatry and clinical neuroscience - 1 Oct 2026
Sorkhou Maryam, Kim Helena K, Farzan Faranak, Foster Jane A, Frey Benicio N, Husain Muhammad I, Kennedy Sidney H, Lam Raymond W, Milev Roumen, Mulsant Benoit H, Müller Daniel J, Quilty Lena C, Soares Claudio N, Taylor Valerie H, Turecki Gustavo, Kloiber Stefan
Abstract excerpt
BACKGROUND: Sex differences in major depressive disorder (MDD) are well documented, but it remains unclear whether sex-related variation in peripheral endocannabinoid system (ECS)-related biomarkers is detectable in MDD. OBJECTIVES: To examine baseline sex differences in ECS-related mRNA expression, DNA methylation, and single nucleotide polymorphisms (SNPs) in MDD, and associations between baseline ECS markers...
Read the complete abstract on PubMedTopics
- Humans
- Major Depressive Disorder
- Male
- Female
